Detalles de la búsqueda
1.
Occupancy-Based Energy Consumption Estimation Improvement through Deep Learning.
Sensors (Basel)
; 23(4)2023 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36850726
2.
Prognostic significance of S100A8-positive immune cells in relation to other immune cell infiltration in pre-invasive and invasive breast cancers.
Cancer Immunol Immunother
; 70(5): 1365-1378, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33146829
3.
Immune microenvironment in ductal carcinoma in situ: a comparison with invasive carcinoma of the breast.
Breast Cancer Res
; 22(1): 32, 2020 03 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-32216826
4.
Application of Small Cell Lung Cancer Molecular Subtyping Markers to Small Cell Neuroendocrine Carcinoma of the Cervix: NEUROD1 as a Poor Prognostic Factor.
Am J Surg Pathol
; 48(3): 364-372, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37981832
5.
Concordance of HER2 status between core needle biopsy and surgical resection specimens of breast cancer: an analysis focusing on the HER2-low status.
Breast Cancer
; 2024 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38643429
6.
Artificial-Intelligence-Assisted Detection of Metastatic Colorectal Cancer Cells in Ascitic Fluid.
Cancers (Basel)
; 16(5)2024 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38473421
7.
Histopathologic image-based deep learning classifier for predicting platinum-based treatment responses in high-grade serous ovarian cancer.
Nat Commun
; 15(1): 4253, 2024 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38762636
8.
Pathologically confirmed pancreatic hamartoma after surgical resection with an aldosterone-producing adrenal tumor: a case report.
J Surg Case Rep
; 2023(8): rjad475, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37614465
9.
Diagnostic Assessment of Deep Learning Algorithms for Frozen Tissue Section Analysis in Women with Breast Cancer.
Cancer Res Treat
; 55(2): 513-522, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36097806
10.
Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16).
Eur J Cancer
; 195: 113386, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37890351
11.
miR-145, miR-205 and miR-451: potential tumor suppressors involved in the progression of in situ to invasive carcinoma of the breast.
Breast Cancer
; 29(5): 814-824, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35451796
12.
Expression of HLA class I is associated with immune cell infiltration and patient outcome in breast cancer.
Sci Rep
; 12(1): 20367, 2022 11 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36437379
13.
Role of CXCL10 in the progression of in situ to invasive carcinoma of the breast.
Sci Rep
; 11(1): 18007, 2021 09 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34504204
14.
Changes and prognostic values of tumor-infiltrating lymphocyte subsets after primary systemic therapy in breast cancer.
PLoS One
; 15(5): e0233037, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32401825
15.
Prognostic implication of ABC transporters and cancer stem cell markers in patients with stage III colon cancer receiving adjuvant FOLFOX-4 chemotherapy.
Oncol Lett
; 17(6): 5572-5580, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31186779
16.
Clinical implications of changes in the diversity of c-MYC copy number variation after neoadjuvant chemotherapy in breast cancer.
Sci Rep
; 8(1): 16668, 2018 11 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30420657
17.
Correction to: miR-145, miR-205 and miR-451: potential tumor suppressors involved in the progression of in situ to invasive carcinoma of the breast.
Breast Cancer
; 30(1): 156, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36334184
18.
Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features and Its Impact on the Risk of Malignancy in the Bethesda System for Reporting Thyroid Cytopathology: An Institutional Experience.
J Pathol Transl Med
; 52(3): 171-178, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29614546
19.
Microinvasive Carcinoma versus Ductal Carcinoma In Situ: A Comparison of Clinicopathological Features and Clinical Outcomes.
J Breast Cancer
; 21(2): 197-205, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29963116
20.
Negative Conversion of Progesterone Receptor Status after Primary Systemic Therapy Is Associated with Poor Clinical Outcome in Patients with Breast Cancer.
Cancer Res Treat
; 50(4): 1418-1432, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29361816